Frankfurt - Delayed Quote EUR

Owens & Minor, Inc. (6OM.F)

5.95
-0.10
(-1.65%)
At close: May 23 at 3:56:47 PM GMT+2
Loading Chart for 6OM.F
  • Previous Close 6.05
  • Open 6.05
  • Bid 5.65 x 20000
  • Ask 5.70 x 20000
  • Day's Range 5.95 - 6.05
  • 52 Week Range 5.65 - 16.10
  • Volume 1,900
  • Avg. Volume 0
  • Market Cap (intraday) 455.854M
  • Beta (5Y Monthly) 1.38
  • PE Ratio (TTM) --
  • EPS (TTM) -4.22
  • Earnings Date Jul 31, 2025 - Aug 4, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date Dec 14, 2021
  • 1y Target Est --

Owens & Minor, Inc., together with its subsidiaries, operates as a healthcare solutions company worldwide. The company operates in two segments, Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers. Its portfolio of medical and surgical supplies includes branded products and its proprietary products. This segment also offers services to healthcare providers, including supplier management, analytics, inventory management, and clinical supply management; and various programs to provide outsourced logistics and marketing solutions to its suppliers. The Patient Direct segment provides products and services for in-home care and delivery across diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment. This segment also supplies a range of other home medical equipment; and patient care products, including ostomy, wound care, urology, and incontinence and other products and services. The company serves multi-facility networks of healthcare providers, independent hospitals, surgery centers, physicians' practices, and networks of hospitals directly, as well as indirectly through third-party distributors. Owens & Minor, Inc. was founded in 1882 and is based in Glen Allen, Virginia.

www.owens-minor.com

23,200

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 6OM.F

View More

Performance Overview: 6OM.F

Trailing total returns as of 5/23/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

6OM.F
51.63%
S&P 500 (^GSPC)
1.34%

1-Year Return

6OM.F
63.27%
S&P 500 (^GSPC)
10.16%

3-Year Return

6OM.F
81.75%
S&P 500 (^GSPC)
46.03%

5-Year Return

6OM.F
16.73%
S&P 500 (^GSPC)
96.34%

Compare To: 6OM.F

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 6OM.F

View More

Valuation Measures

Annual
As of 5/23/2025
  • Market Cap

    438.06M

  • Enterprise Value

    2.40B

  • Trailing P/E

    --

  • Forward P/E

    3.84

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.05

  • Price/Book (mrq)

    0.90

  • Enterprise Value/Revenue

    0.25

  • Enterprise Value/EBITDA

    94.55

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -3.41%

  • Return on Assets (ttm)

    3.14%

  • Return on Equity (ttm)

    -49.91%

  • Revenue (ttm)

    10.72B

  • Net Income Avi to Common (ttm)

    -365.78M

  • Diluted EPS (ttm)

    -4.22

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    59.44M

  • Total Debt/Equity (mrq)

    397.82%

  • Levered Free Cash Flow (ttm)

    133.97M

Research Analysis: 6OM.F

View More

Company Insights: 6OM.F

Research Reports: 6OM.F

View More

People Also Watch